Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0186
-0.0005 (-2.62%)
At close: Apr 27, 2026
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $982.74 thousand as of April 27, 2026. Its market cap has decreased by -97.42% in one year.
Market Cap
982.74K
Enterprise Value
23.72M
Revenue
390.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from 179.38M to 982.74K, a decrease of -99.45%. That is a compound annual growth rate of -48.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 982.74K | -94.45% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.30M |
| Lyra Therapeutics | 1.26M |
| LakeShore Biopharma | 1.24M |
| Abpro Holdings | 1.16M |
| Evofem Biosciences | 1.15M |
| Windtree Therapeutics | 1.12M |
| International Stem Cell | 1.12M |
| Exousia Pro | 1.09M |